Skip to content

GET ACCESS TO:

Everything
you need.

BBG Advanced Therapies partners with biotech and pharma teams to help move advanced therapies from possibility to patient impact. Backed by five decades of experience, we deliver integrated starting materials, testing, and biomanufacturing solutions designed for reproducibility, reliability, and scale.

BBGAT-key-art-full-comp-10 2

Mask group (1)

Where mission
meets motion.

_DSC5410_R 1

Access an end-to-end service suite covering starting materials, R&D, cryogenic storage, and global logistics.

Advanced therapies advance with the right infrastructure. BBG Advanced Therapies unites the core elements needed for program success.

BBGAT-triangle-pattern 1
Starting Materials Icon-1

RUO and cGMP
leukapheresis collections

Group 10

Allogeneic donor and
autologous patient access

Group 15

A diverse, recallable donor registry with IRB oversight

Group 12

Safety, characterization,
potency, in-process, release,
and stability testing

Advanced Therapies Testing Icon-1

Custom assay development
and technology transfer

Group 27

FDA, EMA, and PDMA-
compliant cleanrooms


Group 28

Scalable systems and integrated
quality management


These aren’t disconnected services. We integrate them intentionally and holistically, so the decisions you make early on support long-term scale, compliance, and performance.

Group 6 (7)

Starting Materials & Collection

Securing qualified donors and managing collection logistics is challenging. Our team partners with you at every stage, from early research to clinical and commercial production, to deliver the right starting materials, with the right specifications, exactly when you need them.

We’ve got you covered.

BBG Advanced Therapies gives you access to research-grade and cGMP
starting materials, and a supply chain that gets them exactly where you need
them, all in accordance with 21 CFR 1271.

Group 17

GMP and RUO-grade
leukopak, cord blood, and
tissue collection

Group 17

Co-located testing and cryopreservation to
streamline timelines

Group 17

Controlled logistics with
validated shippers
worldwide

Group 17

The world’s first mobile leukapheresis center

BBGA-26-018-Graphic-elements-landing-1b 1 (1)

See how integrated access accelerates your program.

DISCUSS YOUR PROGRAM NEEDS
Biorector-IMG_8898-sm-v2 1

Why BBG Advanced Therapies

Group 17

Mission-Driven

Everything we do is grounded in a single purpose: saving and enhancing lives through the healing power of human cells and tissue.

Group 17

Integrated by Design

Starting materials, testing, research support, and biomanufacturing are aligned from the outset.

Group 17

Experienced and Proactive

We understand where challenges arise so we can address them before they slow progress.

Group 17

Built for Forward Motion

Our flexible, reliable infrastructure supports clinical advancement and commercial readiness.

Group 17

Driven by Fortitude

We are steadfast in quality. Relentless in improvement. And always focused on successful outcomes.

PD lad bioreactor_R 1 (1)

Ready to move your program forward?

We are ready to partner with you, aligning starting materials, testing, and manufacturing into one integrated strategy for long-term success.

BBGAT-ATW-Landing-graphics-1 2-1